S&P TSX Capped Composite...

US Dollar vs CAD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

GALT Galectin Therapeutics Inc

2.62

-0.04 (-1.50%)

Jun 14 2024 - Closed

Delayed by 15 minutes

Form 5 - Annual statement of changes in beneficial ownership of securities

Galectin Therapeutics (NASDAQ:GALT)
Historical Stock Chart
From May 2024 to Jun 2024

Click Here for more Galectin Therapeutics Charts.

Galectin Therapeutics (NASDAQ:GALT)
Historical Stock Chart
From Jun 2023 to Jun 2024

Click Here for more Galectin Therapeutics Charts.

Galectin Therapeutics Inc News

Form 8-K - Current report
Wednesday 15 May 2024 (1 month ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Wednesday 15 May 2024 (1 month ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Monday 4 March 2024 (3 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 7 February 2024 (4 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 7 February 2024 (4 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 7 February 2024 (4 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 7 February 2024 (4 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 7 February 2024 (4 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 7 February 2024 (4 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 7 February 2024 (4 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 7 February 2024 (4 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 7 February 2024 (4 months ago) • Edgar (US Regulatory)

More Galectin Therapeutics Inc News Articles

ERHC Energy (CE)

Asia Broadband (PK)

Elite Pharmaceuticals (QB)

Cann American (CE)

Hannover House (PK)

CTR Investments and Cons... (PK)

Anavex Life Sciences

Decentral Life (PK)

Kraig Biocraft Laborator... (QB)

Digital Brand Media and ... (PK)

Intergrated Cannabis Sol... (PK)

Bell Buckle (PK)

Ronn Motor (PK)

Lightwave Logic

Rennova Health (PK)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions